PRINCETON, N.J., April 22, 2013 /PRNewswire/ -- To showcase New Jersey as one of the world's premiere locations for life science companies and medical research, Choose New Jersey, Inc. is collaborating with Lt. Governor Kim Guadagno , the Business Action Center (BAC), BioNJ, the HealthCare Institute of New Jersey (HINJ) and other partners at the BIO International Convention in Chicago on April 22-25, 2013.
This is the third year in a row that Choose New Jersey has led a delegation to BIO International, which is considered the largest biotechnology event in the world. Last year, the conference drew more than 16,500 industry leaders from 49 states and 65 countries, including large delegations from Canada, UK, Germany, France, Japan, South Korea, Spain, Australia, China and Brazil.
"New Jersey offers unrivaled opportunities for pharmaceutical, biotechnology and medical device businesses," said Lt. Governor Guadagno. "BIO International is the perfect forum for sharing our state's competitive advantages with this highly targeted international audience. Simply put, our goal is to attract the businesses that will help sustain and grow the $58 billion economic output that the biopharmaceutical sector already contributes to the Garden State."
Representatives from the New Jersey delegation - the largest from the Garden State to attend this event in recent years - will meet with life science c
|SOURCE Choose New Jersey, Inc.|
Copyright©2012 PR Newswire.
All rights reserved